- Home
- CLB vs PSNL Comparison
CLB vs PSNL Comparison
Compare CLB & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLB
- PSNL
- Stock Information
- Founded
- CLB 1936
- PSNL 2011
- Country
- CLB United States
- PSNL United States
- Employees
- CLB N/A
- PSNL N/A
- Industry
- CLB
- PSNL Medical Specialities
- Sector
- CLB
- PSNL Health Care
- Exchange
- CLB Nasdaq
- PSNL Nasdaq
- Market Cap
- CLB 482.5M
- PSNL 518.8M
- IPO Year
- CLB 1995
- PSNL 2019
- Fundamental
- Price
- CLB $16.47
- PSNL $9.75
- Analyst Decision
- CLB Hold
- PSNL Strong Buy
- Analyst Count
- CLB 2
- PSNL 5
- Target Price
- CLB $12.50
- PSNL $8.70
- AVG Volume (30 Days)
- CLB 683.7K
- PSNL 1.3M
- Earning Date
- CLB 10-22-2025
- PSNL 11-04-2025
- Dividend Yield
- CLB 0.24%
- PSNL N/A
- EPS Growth
- CLB 25.86
- PSNL N/A
- EPS
- CLB 0.68
- PSNL N/A
- Revenue
- CLB $517,501,999.00
- PSNL $80,317,000.00
- Revenue This Year
- CLB N/A
- PSNL N/A
- Revenue Next Year
- CLB $4.31
- PSNL $29.83
- P/E Ratio
- CLB $24.22
- PSNL N/A
- Revenue Growth
- CLB N/A
- PSNL 0.36
- 52 Week Low
- CLB $9.72
- PSNL $2.83
- 52 Week High
- CLB $21.83
- PSNL $10.95
- Technical
- Relative Strength Index (RSI)
- CLB 74.03
- PSNL 64.61
- Support Level
- CLB $11.16
- PSNL $9.40
- Resistance Level
- CLB $17.46
- PSNL $9.93
- Average True Range (ATR)
- CLB 0.83
- PSNL 0.88
- MACD
- CLB 0.61
- PSNL 0.01
- Stochastic Oscillator
- CLB 86.18
- PSNL 62.15
About CLB Core Laboratories Inc.
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.